Search Results:  European Community  (5)

  • Target product profiles for tuberculosis preventive treatment

    The World Health Organization (WHO) has launched target product profiles to drive the rapid development of novel tuberculosis (TB) preventive treatment today. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.

    One quarter of the global population is estimated to be infected with TB and are at greater risk of developing TB disease, especially those with weakened immunity. Treatment of T

    Roles: Everyone: All Users

    Regions: Canada , France , Italy , United Kingdom

    Topics: Global Health

  • COVID-19 Emergency Committee highlights need for response efforts over long term

    The Emergency Committee on COVID-19, convened by the WHO Director-General under the International Health Regulations (2005) (IHR), held its fourth meeting on 31 July. In its statement following the meeting, published today, it expressed “appreciation for WHO and partners’ COVID-19 pandemic response efforts, and highlighted the anticipated lengthy duration of this COVID-19 pandemic, noting the importance of sustained community, national, regional, and global response efforts.”  

    Roles: Everyone: All Users

    Regions: China

    Topics: Coronavirus (COVID-19), Global Health

  • European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings

    The European Medicines Agency announced today that its human medicines committee provided a positive benefit-risk opinion on the use of the Dapivirine Vaginal Ring (DPV-VR) for HIV prevention. WHO stresses that when providing HIV prevention for women it is always critical to provide these alongside other services including STI diagnosis and treatment, HIV testing and links to antiretroviral therapy for all women who test positive and a range of contraception options.

    Roles: Everyone: All Users

    Regions: Kenya

    Topics: Global Health, Global Women's Issues

  • More than 150 countries engaged in COVID-19 vaccine global access facility

    • Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC)
    • The COVAX Facility, and the AMC within it, is designed to guarantee rapid, fair and equitable access to COVID-19 vaccines for every country in the world, rich and poor, to make rapid progress towards slowing the pandemic 
    • Interest from governments represen

      Roles: Everyone: All Users

      Regions: Argentina, Canada , Norway , United Kingdom

      Topics: Coronavirus (COVID-19), Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

    • #EndTB Webinar: From Policy to Practice: Rolling out new WHO guidelines on rapid diagnostics and drug-resistant TB treatment

      A special #EndTB Webinar organized by the World Health Organization (WHO) to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment. The aim of the webinar is to facilitate better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders. This will translate to earlier access to quality diagnosis and treatment, and better outcomes for the millions affected by TB and drug-resistant TB.

      Roles: Everyone: All Users

      Regions: United Kingdom

      Topics: Global Health, Science, Technology, and Innovation

    Results 1 - 5 of 5

  • Regions









































































































































































































































  • Topics